Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 182

1.

Characterization and proteomic analysis of ovarian cancer-derived exosomes.

Liang B, Peng P, Chen S, Li L, Zhang M, Cao D, Yang J, Li H, Gui T, Li X, Shen K.

J Proteomics. 2013 Mar 27;80:171-82. doi: 10.1016/j.jprot.2012.12.029. Epub 2013 Jan 16.

PMID:
23333927
2.

Exosomes mediated pentose phosphate pathway in ovarian cancer metastasis: a proteomics analysis.

Yi H, Zheng X, Song J, Shen R, Su Y, Lin D.

Int J Clin Exp Pathol. 2015 Dec 1;8(12):15719-28. eCollection 2015.

3.

Ovarian cancer cell invasiveness is associated with discordant exosomal sequestration of Let-7 miRNA and miR-200.

Kobayashi M, Salomon C, Tapia J, Illanes SE, Mitchell MD, Rice GE.

J Transl Med. 2014 Jan 6;12:4. doi: 10.1186/1479-5876-12-4.

4.

In-depth proteomic analyses of ovarian cancer cell line exosomes reveals differential enrichment of functional categories compared to the NCI 60 proteome.

Sinha A, Ignatchenko V, Ignatchenko A, Mejia-Guerrero S, Kislinger T.

Biochem Biophys Res Commun. 2014 Mar 21;445(4):694-701. doi: 10.1016/j.bbrc.2013.12.070. Epub 2014 Jan 14.

PMID:
24434149
5.

Identification and proteomic analysis of osteoblast-derived exosomes.

Ge M, Ke R, Cai T, Yang J, Mu X.

Biochem Biophys Res Commun. 2015 Nov 6;467(1):27-32. doi: 10.1016/j.bbrc.2015.09.135. Epub 2015 Sep 28.

PMID:
26420226
6.

Proteome profiling of neuroblastoma-derived exosomes reveal the expression of proteins potentially involved in tumor progression.

Marimpietri D, Petretto A, Raffaghello L, Pezzolo A, Gagliani C, Tacchetti C, Mauri P, Melioli G, Pistoia V.

PLoS One. 2013 Sep 19;8(9):e75054. doi: 10.1371/journal.pone.0075054. eCollection 2013.

7.

Proteomics analysis of bladder cancer exosomes.

Welton JL, Khanna S, Giles PJ, Brennan P, Brewis IA, Staffurth J, Mason MD, Clayton A.

Mol Cell Proteomics. 2010 Jun;9(6):1324-38. doi: 10.1074/mcp.M000063-MCP201. Epub 2010 Mar 11.

8.

Claudin-containing exosomes in the peripheral circulation of women with ovarian cancer.

Li J, Sherman-Baust CA, Tsai-Turton M, Bristow RE, Roden RB, Morin PJ.

BMC Cancer. 2009 Jul 20;9:244. doi: 10.1186/1471-2407-9-244.

9.

Proteomic analysis of melanoma-derived exosomes by two-dimensional polyacrylamide gel electrophoresis and mass spectrometry.

Mears R, Craven RA, Hanrahan S, Totty N, Upton C, Young SL, Patel P, Selby PJ, Banks RE.

Proteomics. 2004 Dec;4(12):4019-31.

PMID:
15478216
10.

Comparison of ultracentrifugation, density gradient separation, and immunoaffinity capture methods for isolating human colon cancer cell line LIM1863-derived exosomes.

Tauro BJ, Greening DW, Mathias RA, Ji H, Mathivanan S, Scott AM, Simpson RJ.

Methods. 2012 Feb;56(2):293-304. doi: 10.1016/j.ymeth.2012.01.002. Epub 2012 Jan 21.

PMID:
22285593
11.

A protocol for exosome isolation and characterization: evaluation of ultracentrifugation, density-gradient separation, and immunoaffinity capture methods.

Greening DW, Xu R, Ji H, Tauro BJ, Simpson RJ.

Methods Mol Biol. 2015;1295:179-209. doi: 10.1007/978-1-4939-2550-6_15.

PMID:
25820723
12.

Characterization of exosomes derived from ovarian cancer cells and normal ovarian epithelial cells by nanoparticle tracking analysis.

Zhang W, Peng P, Kuang Y, Yang J, Cao D, You Y, Shen K.

Tumour Biol. 2016 Mar;37(3):4213-21. doi: 10.1007/s13277-015-4105-8. Epub 2015 Oct 22.

PMID:
26490993
13.

Proteomic profiling of exosomes leads to the identification of novel biomarkers for prostate cancer.

Duijvesz D, Burnum-Johnson KE, Gritsenko MA, Hoogland AM, Vredenbregt-van den Berg MS, Willemsen R, Luider T, Paša-Tolić L, Jenster G.

PLoS One. 2013 Dec 31;8(12):e82589. doi: 10.1371/journal.pone.0082589. eCollection 2013.

14.

Two distinct populations of exosomes are released from LIM1863 colon carcinoma cell-derived organoids.

Tauro BJ, Greening DW, Mathias RA, Mathivanan S, Ji H, Simpson RJ.

Mol Cell Proteomics. 2013 Mar;12(3):587-98. doi: 10.1074/mcp.M112.021303. Epub 2012 Dec 10.

15.

Triple SILAC quantitative proteomic analysis reveals differential abundance of cell signaling proteins between normal and lung cancer-derived exosomes.

Clark DJ, Fondrie WE, Yang A, Mao L.

J Proteomics. 2016 Feb 5;133:161-169. doi: 10.1016/j.jprot.2015.12.023. Epub 2015 Dec 29.

PMID:
26739763
16.

Systemic presence and tumor-growth promoting effect of ovarian carcinoma released exosomes.

Keller S, König AK, Marmé F, Runz S, Wolterink S, Koensgen D, Mustea A, Sehouli J, Altevogt P.

Cancer Lett. 2009 Jun 8;278(1):73-81. doi: 10.1016/j.canlet.2008.12.028. Epub 2009 Feb 1.

PMID:
19188015
17.

Exosomal particles secreted by prostate cancer cells are potent mRNA and protein vehicles for the interference of tumor and tumor environment.

Rauschenberger L, Staar D, Thom K, Scharf C, Venz S, Homuth G, Schlüter R, Brandenburg LO, Ziegler P, Zimmermann U, Weitschies W, Völker U, Lendeckel U, Walther R, Burchardt M, Stope MB.

Prostate. 2016 Mar;76(4):409-24. doi: 10.1002/pros.23132. Epub 2015 Dec 8.

PMID:
26643154
18.

MicroRNA and protein profiling of brain metastasis competent cell-derived exosomes.

Camacho L, Guerrero P, Marchetti D.

PLoS One. 2013 Sep 16;8(9):e73790. doi: 10.1371/journal.pone.0073790. eCollection 2013.

19.

Exosome-derived miRNAs and ovarian carcinoma progression.

Vaksman O, Tropé C, Davidson B, Reich R.

Carcinogenesis. 2014 Sep;35(9):2113-20. doi: 10.1093/carcin/bgu130. Epub 2014 Jun 12.

PMID:
24925027
20.

Molecular characterization of exosome-like vesicles from breast cancer cells.

Kruger S, Abd Elmageed ZY, Hawke DH, Wörner PM, Jansen DA, Abdel-Mageed AB, Alt EU, Izadpanah R.

BMC Cancer. 2014 Jan 27;14:44. doi: 10.1186/1471-2407-14-44.

Supplemental Content

Support Center